Pharmala Biotech Quote - MDMA | ADVFN

S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
Canada
CSE
Pharmala Biotech Holdings Inc (MDMA) Share Price

Pharmala Biotech Holdings Inc (MDMA)

0.26

0.01

(4.00%)

Closed 08 February 8:00AM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Current Price

0.26

Bid

0.255

Offer

0.265

Volume

262,209

0.255 Day's Range 0.27

0.065 52 Week Range 0.34

Previous Close

0.25

Open

0.26

Last Trade

Last Trade Time

Average Volume (3m)

329,506

Financial Volume

-

VWAP

-

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.03	13.0434782609	0.23	0.29	0.2	232620	0.26091468	CS
4	-0.005	-1.88679245283	0.265	0.31	0.195	239073	0.25280488	CS
12	-0.055	-17.4603174603	0.315	0.34	0.195	329506	0.27696234	CS
26	0.165	173.684210526	0.095	0.34	0.065	344943	0.21400214	CS
52	-0.05	-16.1290322581	0.31	0.34	0.065	362056	0.19575526	CS
156	0.2	333.333333333	0.06	0.54	0.02	555014	0.19561118	CS
260	-0.18	-40.9090909091	0.44	0.54	0.02	558764	0.19216149	CS

MDMA - Frequently Asked Questions (FAQ)

What is the current Pharmala Biotech share price?

The current share price of Pharmala Biotech is $ 0.26

What is the 1 year trading range for Pharmala Biotech share price?

Pharmala Biotech has traded in the range of $ 0.065 to $ 0.34 during the past year

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BLKBLOK Technologies Inc	$ 26.38 (527,500.00%)	2.36k
NXU.XNexco Resources Inc	$ 0.01 (100.00%)	194.5k
KASHIntellabridge Technology Corporation	$ 0.12 (84.62%)	364.96k
BATTDark Star Minerals Inc	$ 0.11 (69.23%)	129.35k
SPSSweet Poison Spirits Inc	$ 0.20 (66.67%)	1,000
BARBarranco Gold Mining Corp	$ 0.17 (-78.48%)	11.87k
STPHSteep Hill Inc	$ 0.05 (-52.38%)	77.31k
AVM.XAvarone Metals Inc	$ 0.005 (-50.00%)	2.08M
AWRAurwest Resources Corporation	$ 0.005 (-50.00%)	112.45k
TAURTaurus Gold Corp	$ 0.01 (-50.00%)	395.48k
CACRKWG Resources Inc	$ 0.02 (0.00%)	4.45M
PKKPeak Fintech Group Inc	$ 0.04 (0.00%)	2.99M
QIMCQuebec Innovative Materials Corp	$ 0.08 (0.00%)	2.3M
AVM.XAvarone Metals Inc	$ 0.005 (-50.00%)	2.08M
PAUProvenance Gold Corp	$ 0.21 (-12.50%)	1.78M

lolroflmao

lolroflmao 3 months ago

PharmAla Reaches Agreement In Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License

https://pharmala.ca/media/2024/11/pharmala-reaches-agreement-in-principle-to-supply-mdma-to-clinical-trial-in-exchange-for-full-data-license

lolroflmao

lolroflmao 3 months ago

News: PharmAla to supply LaNeo MDMA for Clinical Trial at Yale

https://pharmala.ca/media/2024/11/pharmala-to-supply-laneo-mdma-for-clinical-trial-at-yale

lolroflmao

lolroflmao 3 months ago

PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA Press Release | 10/21/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Mt-Sinai-Hospital-with-LaNeo-MDMA?id=456329

lolroflmao

lolroflmao 3 months ago

PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA Press Release | 10/08/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-the-University-of-Texas-San-Antonio-with-novel-dosage-form-of-LaNeo-MDMA?id=455196

lolroflmao

lolroflmao 3 months ago

PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMAPress Release | 10/02/2024
https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Harvard-Medical-Schools-Maclean-Hospital-with-LaNeo-MDMA?id=454666

lolroflmao

lolroflmao 3 months ago

PharmAla to supply Johns Hopkins Medicine for Clinical TrialPress Release | 09/11/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Johns-Hopkins-Medicine-for-Clinical-Trial?id=452770

Dewayne18

Dewayne18 2 years ago

$MDMA New Short Call: Shorts in at 30 cents today. Stay tuned tomorrow for details of its pending doom. Last call 34% in less than 2 days.

Dewayne18

Dewayne18 2 years ago

$MDMA SHORT ALERT!!!

Company up on lousy $50,000 deal.... Shorts in at 38 cents CDN.

Quick 30%

Act Now!!!

Dewayne18

Dewayne18 2 years ago

$MDMA is looking like the perfect short. The SP is racing up and the company only has 700K left with shares doubling up in the past 12 months. Over the past 12 months cash went down by 1.2 million.

Forcealpine

Forcealpine 3 years ago

It looks like this IPO has gone similarly to all psych companies have. The industry needs a massive correction, but that cannot happen until government stop obsessing over vaccines and start promoting alternative solutions to the gigantic mental health crisis ongoing and perpetuating daily while being ignored. MDMA looks promising and I'll be keeping a very close eye on its news and resulting share price.

Pharmala Biotech

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions